1. |
Hügle T, Geurts J. What drives osteoarthritis?-synovial versus subchondral bone pathology. Rheumatology (Oxford), 2016. [Epub ahead of print].
|
2. |
Henrotin Y, Pesesse L, Sanchez C. Subchondrol bone and osteosrthritis: biological and cellur aspects. Osteoporos Int, 2012, 23 Suppl 8: S847-851.
|
3. |
于德刚, 汤亭亭, 朱振安. 骨关节炎软骨下骨改变及其作用研究进展. 国际骨科学杂志, 2015, 36(3): 172-178.
|
4. |
Daghestani HN, Kraus VB. Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage, 2015, 23(11): 1890-1896.
|
5. |
Imamura M, Ezquerro F, Marcon Alfieri F, et al. Serum levels of pro-inflammatory cytokines in painful knee osteoarthritis and sensitization. Int J Inflam, 2015, 2015: 329792.
|
6. |
Moskowitz RW. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage, 2006, 14(1): 1-2.
|
7. |
Fan JJ, Cao LG, Wu T, et al. The dose-effect of icariin on the proliferation and osteogenic differentiation of human bone mesenchymal stem cells. Molecules, 2011, 16(12): 10123-10133.
|
8. |
Ma HP, Ming LG, Ge BF, et al. Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem, 2011, 112(3): 916-923.
|
9. |
Hsieh TP, Sheu SY, Sun JS, et al. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE (2) synthesis. Phytomedicine, 2011, 18(2-3): 176-185.
|
10. |
翟吉良, 翁习生, 邱贵兴. 骨关节炎动物模型的建立及选择.中国矫形外科杂志, 2007, 15(11): 843-845.
|
11. |
Van Spil WE, Welsing PM, Bierma-Zeinstra SM, et al. The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: data from CHECK. Osteoarthritis Cartilage, 2015, 23(8): 1388-1397.
|
12. |
Ishijima M, Kaneko H, Kaneko K. The evolving role of biomarkers for osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 2014, 6(4): 144-153.
|
13. |
Zoch ML, Clements TL, Riddle RC. New insights into the biology of osteocalcin. Bone, 2016, 82: 42-49.
|
14. |
Papalia R, Vadalà G, Torre G, et al. The cytokinome in osteoarthritis, a new paradigm in diagnosis and prognosis of cartilage disease. J Biol Regul Homeost Agents, 2016, 30(4 Suppl 1): 77-83.
|
15. |
Latourte A, Cherifi C, Maillet J, et al. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis. Ann Rheum Dis, 2016, 76(4): 748-755.
|
16. |
Mabey T, Honsawek S. Cytokines as biochemical markers for knee osteoarthritis. World J Orthop, 2015, 6(1): 95-105.
|
17. |
石婷, 高戈, 闫祖炜, 等. 兔实验性骨关节炎六种血清学生物标志物的变化. 细胞与分子免疫学杂志, 2015, 31(12): 1620-1623, 1628.
|
18. |
查振刚, 黄良任, 姚平, 等. 膝骨关节炎患者血清 TNF-α 与 IL-6 水平及其临床意义. 广东医学, 2005, 26(2): 191-193.
|
19. |
Charlier E, Relic B, Deroyer C, et al. Insights on Molecular Mechanisms of Chondrocytes Death in Osteoarthritis. Int J Mol Sci, 2016, 17(12): 2146.
|
20. |
Hosseinzadeh A, Kamrava SK, Joghataei MT, et al. Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res, 2016, 61(4): 411-425.
|
21. |
Zeng L, Rong XF, Li RH, Wu XY. Icariin inhibits MMP1, MMP3 and MMP13 expression through MAPK pathways in IL1β stimulated SW1353 chondrosarcoma cells. Mol Med Rep, 2017, 15(5): 2853-2858.
|
22. |
Zhang L, Zhang X, Li KF, et al. Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro. Phytother Res, 2012, 26(9): 1385-1392.
|
23. |
Fu S, Yang L, Hong H, et al. Wnt/β-catenin signaling is involved in the Icariin induced proliferation of bone marrow mesenchymal stem cells. J Tradit Chin Med, 2016, 36(3): 360-368.
|
24. |
Qin S, Zhou W, Liu S, et al. Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling. Int J Clin Exp Med, 2015, 8(5): 7125-7133.
|
25. |
Wu Y, Xia L, Zhou Y, et al. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif, 2015, 48(3): 375-384.
|